Apolipoprotein E Receptor Pathway Modulator (ApoE Receptor Modulator)

Apolipoprotein E (ApoE) receptor pathway modulators are molecules that influence the activity of ApoE receptors, which play a central role in lipid metabolism, neuronal signaling, and neurodegenerative diseases such as Alzheimer's disease. These modulators can affect how ApoE interacts with its receptors, thereby altering downstream cellular processes including lipid uptake, amyloid-β (Aβ) metabolism, synaptic function, and inflammation. Key receptors include LDLR, LRP1, APOER2/LRP8, and VLDLR. Modulation of the ApoE receptor pathway has significant implications in neurodegenerative diseases, particularly Alzheimer's disease, by affecting Aβ aggregation/clearance and synaptic plasticity. Modulators may act by altering conformation or expression levels of either apoE or its receptors, or affecting post-translational modifications that change binding affinity. Targeting this pathway offers potential strategies for treating hyperlipidemia/atherosclerosis or modifying CNS pathologies such as Alzheimer’s disease.

Other names

ApoE receptor modulatorApolipoprotein E receptor pathwayLDLR pathway modulatorLRP1 pathway modulatorAPOER2/LRP8 pathway modulatorVLDLR pathway modulator

Alters ligand-receptor interactions affecting downstream pathways